Arbutus Biopharma Corp Preferred Stock, Dividend Rate, Percentage
Arbutus Biopharma Corp (ABUS) reported Preferred Stock, Dividend Rate, Percentage of 8.75% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2023-03-02
- Arbutus Biopharma Corp preferred stock, dividend rate, percentage for fiscal 2022 was 8.75%, a 0.00% change from fiscal 2021.
- Arbutus Biopharma Corp preferred stock, dividend rate, percentage for fiscal 2021 was 8.75%, a 0.00% change from fiscal 2020.
- Arbutus Biopharma Corp preferred stock, dividend rate, percentage for fiscal 2020 was 8.75%.
| Period end | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|
| 2022-12-31 | 8.75% 10-K · filed 2023-03-02 |
| 2021-12-31 | 8.75% 10-K · filed 2022-03-03 |
| 2020-12-31 | 8.75% 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |